To understand how peptides work, start with one idea: most peptides are messengers. A cell releases a peptide, the peptide travels to its target, and it binds to a specific receptor, usually on the outer surface of another cell. That binding switches on a chain of events inside the cell. Some peptides work differently, for example by directly damaging microbes. This guide explains the main mechanisms in plain English, using well-studied examples, and describes why most natural peptides act only briefly.
Key Takeaways
- Many peptides act as hormones, growth factors, neurotransmitters, ion channel ligands, or anti-infective agents [1].
- They usually bind to receptors on the cell surface with high affinity and specificity, triggering effects inside the cell [1].
- Many natural peptides activate G protein-coupled receptors (GPCRs), and a 2020 review counted nearly 50 GPCR-targeting peptide drugs that had reached approval (approval status differs by country) [2].
- Antimicrobial peptides are a separate, ancient defense system used by both animals and plants [3].
- Natural peptides are often short-lived because enzymes break them down and the kidneys clear them quickly [4][5].
- A mechanism shown in cells or animals does not prove an effect in humans.
The Big Picture: Lock and Key
A useful mental model is a lock and key. The peptide is the key, and the receptor, a protein embedded in a cell membrane, is the lock. When the right key fits, the receptor changes shape and passes a signal into the cell.
Two features make peptides good keys:
- Specificity. A peptide's exact sequence and shape let it fit particular receptors and not others. Therapeutic peptides bind their targets with high affinity and specificity [1].
- Surface action. Most peptides cannot easily cross the cell membrane [1], so they typically act on receptors at the cell surface rather than inside the cell.
Because peptides are chains of amino acids, a single change in sequence can alter which receptor they fit or how long they survive. For background, see What Are Peptides? and Amino Acids: The Building Blocks of Peptides.
How Peptides Work Through Receptors
G protein-coupled receptors (GPCRs)
GPCRs are a large family of receptors that loop back and forth through the cell membrane. When a signaling molecule binds on the outside, the receptor activates partner proteins (G proteins) on the inside, which then trigger downstream signals.
Many of the body's own peptides activate GPCRs. A 2020 review in Nature Reviews Drug Discovery reported that nearly 50 GPCR-targeting peptide drugs had been approved at the time of writing, most for metabolic disease or cancer [2]. As with any medicine, whether and for what a product is approved differs between jurisdictions. The review also noted that most existing peptide therapeutics are agonists, meaning molecules that activate a receptor, typically designed by modifying the natural peptide's sequence [2].
Agonists and antagonists
- An agonist turns a receptor on, mimicking the natural signal.
- An antagonist occupies the receptor without switching it on, blocking the natural signal.
The brain hormone GnRH (gonadotropin-releasing hormone), a 10-amino-acid peptide, shows both. Modifying its sequence produced leuprolide, which has GnRH-like activity, and degarelix, which acts as a GnRH antagonist by competitively binding the GnRH receptor [1].
A Worked Example: GLP-1
Glucagon-like peptide-1 (GLP-1) is one of the best-studied peptide hormones, and it shows several key ideas at once [6]:
- Where it is made: GLP-1 is a 30-amino-acid peptide produced by endocrine L-cells in the intestinal lining, by processing a larger precursor protein called proglucagon.
- When it is released: In response to eating.
- What it does: Its main actions are to stimulate insulin secretion and inhibit glucagon secretion, helping to limit rises in blood glucose after meals. It also slows gastrointestinal motility and appears to act as a physiological regulator of appetite and food intake.
- How long it lasts: GLP-1 is "extremely rapidly" inactivated by the enzyme dipeptidyl peptidase-IV (DPP-IV), even before it leaves the gut.
The GLP-1 receptor is found in the pancreas, gastrointestinal tract, heart, lungs, kidneys, and brain [7]. That wide distribution helps explain how one peptide can influence several body systems.
GLP-1 also shows why peptide research often focuses on half-life. Natural GLP-1 lasts only minutes in circulation, so researchers designed modified versions that survive far longer [7]. Our article on peptide half-life explains how.
Other Ways Peptides Act
| Role | How it works (simplified) | Example |
|---|---|---|
| Hormone | Released into the blood, acts on distant tissues via receptors | Insulin, GLP-1 [1][6] |
| Neurotransmitter / neuropeptide | Released by nerve cells to signal nearby cells | Calcitonin gene-related peptide (CGRP), the primary neurotransmitter of capsaicin-sensitive sensory nerves [1] |
| Ion channel ligand | Binds to channels that control ion flow across membranes | Ziconotide, derived from a cone snail peptide, acts on N-type calcium channels [1] |
| Antimicrobial defense | Directly attacks microbes | Antimicrobial peptides of animals and plants [3] |
Antimicrobial peptides: a different strategy
Not every peptide works through a receptor. Both animals and plants produce potent, broad-spectrum antimicrobial peptides that help defend against bacteria, fungi, viruses, and protozoa [3]. Zasloff's widely cited 2002 review in Nature describes them as part of how multicellular organisms coexist with microbes, and discusses their potential as templates for new anti-infective drugs [3].
Why Natural Peptides Act Only Briefly
If peptides are such precise messengers, why don't their effects last? Because the body is built to switch signals off quickly. Two processes dominate [4][5]:
- Enzymatic breakdown (proteolysis). Enzymes called proteases and peptidases cut peptide bonds. DPP-IV and GLP-1 are a clear example [6].
- Kidney clearance. Fast clearance by the kidneys is a common reason for the short plasma half-lives of peptides [4].
Natural peptides also tend to have poor absorption and low membrane permeability [5]. These properties help explain why many peptide medicines are injected rather than swallowed.
For the chemistry of peptide breakdown outside the body, such as in a vial, see How Peptides Degrade.
Mechanism Is Not the Same as Evidence
It is easy to read "peptide X binds receptor Y" and jump to "peptide X does Z in people". Be careful. A mechanism shown in a dish of cells, or in mice, is only a starting point. Species differ in receptors, metabolism, and half-life. The same molecule can last hours in a rat and days in a human [7][8]. Only well-designed human clinical trials can show whether an effect occurs in people and whether it is safe.
To learn how to weigh these kinds of evidence, read How to Judge Peptide Research and Investigational Compounds and Clinical Trial Phases.
Frequently Asked Questions
How do peptides send signals?
Most bind to specific receptors on the surface of target cells. The binding changes the receptor's shape, which triggers a cascade of signals inside the cell [1][2].
What is a peptide receptor?
A receptor is a protein, usually embedded in a cell membrane, that recognizes a specific signaling molecule. Many peptide receptors belong to the G protein-coupled receptor (GPCR) family [2].
Can peptides enter cells?
Generally not easily. Peptides have weak membrane permeability, which is why most act on targets outside the cell [1].
Why do peptides break down so quickly in the body?
Enzymes cleave their peptide bonds and the kidneys filter them out, so many natural peptides have short half-lives [4][5].
What is the difference between a peptide agonist and antagonist?
An agonist activates a receptor. An antagonist blocks it. Leuprolide (GnRH-like activity) and degarelix (a GnRH antagonist) are both derived from the natural GnRH sequence [1].
Do all peptides work through receptors?
No. Antimicrobial peptides, for example, act directly against microbes as part of innate defense [3].
References
- Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7(1):48. https://doi.org/10.1038/s41392-022-00904-4 ↗
- Davenport AP, Scully CCG, de Graaf C, Brown AJH, Maguire JJ. Advances in therapeutic peptides targeting G protein-coupled receptors. Nat Rev Drug Discov. 2020;19(6):389–413. https://doi.org/10.1038/s41573-020-0062-z ↗
- Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415(6870):389–395. https://doi.org/10.1038/415389a ↗
- Werle M, Bernkop-Schnürch A. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids. 2006;30(4):351–367. https://doi.org/10.1007/s00726-005-0289-3 ↗
- Di L. Strategic approaches to optimizing peptide ADME properties. AAPS J. 2015;17(1):134–143. https://doi.org/10.1208/s12248-014-9687-3 ↗
- Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409–1439. https://doi.org/10.1152/physrev.00034.2006 ↗
- Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide. Front Endocrinol (Lausanne). 2019;10:155. https://doi.org/10.3389/fendo.2019.00155 ↗
- European Medicines Agency. Ozempic (semaglutide): EPAR – Product Information (Summary of Product Characteristics), section 5.2. https://www.ema.europa.eu/en/documents/product-information/ozempic-epar-product-information_en.pdf ↗
Educational disclaimer: This article is for general educational purposes only. It is not medical, legal, or regulatory advice, and it does not recommend or describe the use of any product. For health questions, consult a qualified healthcare professional. For regulatory questions, consult the relevant regulatory authority in your jurisdiction.